Skip to main content

Advertisement

Log in

A cross-sectional comparative study on chronic ocular manifestations of Stevens–Johnson syndrome and toxic epidermal necrolysis in Chinese eyes: a 15-year case series

  • Original Paper
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

To compare the chronic ocular manifestations in Stevens–Johnson syndrome and toxic epidermal necrolysis patients from a 15-year cohort.

Methods

All SJS and TEN patients admitted to our burn intensive care unit between 1999 and 2014 were invited for assessment. Slit-lamp examination was performed, and ocular condition was graded according to the Sotozono scoring System, which depended on the extent of cornea, conjunctiva and lid involvement. Tear osmolarity was also measured.

Results

A total of 18 SJS and 4 TEN cases with an average of 92 and 135 months from disease onset were included. The average age of onset was 46.4 ± 16.6 in SJS and 43.5 ± 19.3 in TEN patients. The LogMAR visual acuity was 0.209 ± 0.591 in SJS and 0.489 ± 0.688 in TEN patients (p = 0.048). The average total Sotozono score was 3.75 ± 7.32 in SJS and 6.88 ± 9.49 in TEN (p = 0.358). Neither the age of onset (p = 0.787), length of follow-up (p = 0.256) nor disease type (SJS vs TEN, p = 0.188) predicted the Sotozono score. There was a statistically significant correlation between Sotozono score and LogMAR VA (r s = 0.437, p = 0.003).

Conclusion

The average total Sotozono score was higher in the TEN group than in the SJS group, but the difference was not statistically significant. Nevertheless, the score correlated with the visual acuity which was statistically worse in the TEN group.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kohanim S, Palioura S, Saeed HN, Akpek EK, Amescua G, Basu S, Blomquist PH, Bouchard CS, Dart JK, Gai X, Gomes JA, Gregory DG, Iyer G, Jacobs DS, Johnson AJ, Kinoshita S, Mantagos IS, Mehta JS, Perez VL, Pflugfelder SC, Sangwan VS, Sippel KC, Sotozono C, Srinivasan B, Tan DT, Tandon R, Tseng SC, Ueta M, Chodosh J (2016) Stevens–Johnson syndrome/toxic epidermal necrolysis—a comprehensive review and guide to therapy. I. Systemic disease. Ocul Surf 14:2–19

    Article  PubMed  Google Scholar 

  2. Roujeau JC (1994) The spectrum of Stevens–Johnson syndrome and toxic epidermal necrolysis: a clinical classification. J Invest Dermatol 102:28s–30s

    Article  PubMed  CAS  Google Scholar 

  3. Khalili B, Bahna SL (2006) Pathogenesis and recent therapeutic trends in Stevens–Johnson syndrome and toxic epidermal necrolysis. Ann Allergy Asthma Immunol 97:272–280; quiz 281–273, 320

  4. Diphoorn J, Cazzaniga S, Gamba C, Schroeder J, Citterio A, Rivolta AL, Vighi GD, Naldi L (2016) Incidence, causative factors and mortality rates of Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in northern Italy: data from the REACT registry. Pharmacoepidemiol Drug Saf 25:196–203

    Article  PubMed  CAS  Google Scholar 

  5. Hsu DY, Brieva J, Silverberg NB, Silverberg JI (2016) Morbidity and mortality of Stevens–Johnson syndrome and toxic epidermal necrolysis in United States adults. J Invest Dermatol 136:1387–1397

    Article  PubMed  CAS  Google Scholar 

  6. Lopez-Garcia JS, Rivas Jara L, Garcia-Lozano CI, Conesa E, de Juan IE (2011) Murube del Castillo J: ocular features and histopathologic changes during follow-up of toxic epidermal necrolysis. Ophthalmology 118:265–271

    Article  PubMed  Google Scholar 

  7. Chang YS, Huang FC, Tseng SH, Hsu CK, Ho CL, Sheu HM (2007) Erythema multiforme, Stevens–Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management. Cornea 26:123–129

    Article  PubMed  Google Scholar 

  8. Correia O, Chosidow O, Saiag P, Bastuji-Garin S, Revuz J, Roujeau JC (1993) Evolving pattern of drug-induced toxic epidermal necrolysis. Dermatology (Basel, Switzerland) 186:32–37

  9. Oplatek A, Brown K, Sen S, Halerz M, Supple K, Gamelli RL (2006) Long-term follow-up of patients treated for toxic epidermal necrolysis. J Burn Care Res 27:26–33

    Article  PubMed  Google Scholar 

  10. Power WJ, Ghoraishi M, Merayo-Lloves J, Neves RA, Foster CS (1995) Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens–Johnson syndrome/toxic epidermal necrolysis disease spectrum. Ophthalmology 102:1669–1676

    Article  PubMed  CAS  Google Scholar 

  11. Revuz J, Penso D, Roujeau JC, Guillaume JC, Payne CR, Wechsler J, Touraine R (1987) Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients. Arch Dermatol 123:1160–1165

    Article  PubMed  CAS  Google Scholar 

  12. Sotozono C, Ang LP, Koizumi N, Higashihara H, Ueta M, Inatomi T, Yokoi N, Kaido M, Dogru M, Shimazaki J, Tsubota K, Yamada M, Kinoshita S (2007) New grading system for the evaluation of chronic ocular manifestations in patients with Stevens–Johnson syndrome. Ophthalmology 114:1294–1302

    Article  PubMed  Google Scholar 

  13. Van Zyl L, Carrara H, Lecuona K (2014) Prevalence of chronic ocular complications in Stevens–Johnson syndrome and toxic epidermal necrolysis. Middle East Afr J Ophthalmol 21:332–335

    Article  PubMed  PubMed Central  Google Scholar 

  14. De Rojas MV, Dart JK, Saw VP (2007) The natural history of Stevens Johnson syndrome: patterns of chronic ocular disease and the role of systemic immunosuppressive therapy. Br J Ophthalmol 91:1048–1053

    Article  PubMed  PubMed Central  Google Scholar 

  15. Williams GP, Tomlins PJ, Denniston AK, Southworth HS, Sreekantham S, Curnow SJ, Rauz S (2013) Elevation of conjunctival epithelial CD45INTCD11b(+)CD16(+)CD14(-) neutrophils in ocular Stevens–Johnson syndrome and toxic epidermal necrolysis. Invest Ophthalmol Vis Sci 54:4578–4585

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  16. Yip LW, Thong BY, Lim J, Tan AW, Wong HB, Handa S, Heng WJ (2007) Ocular manifestations and complications of Stevens–Johnson syndrome and toxic epidermal necrolysis: an Asian series. Allergy 62:527–531

    Article  PubMed  CAS  Google Scholar 

  17. Chang VS, Chodosh J, Papaliodis GN (2016) Chronic ocular complications of Stevens–Johnson syndrome and toxic epidermal necrolysis: the role of systemic immunomodulatory therapy. Semin Ophthalmol 31:178–187

    Article  PubMed  CAS  Google Scholar 

  18. Morales ME, Purdue GF, Verity SM, Arnoldo BD, Blomquist PH (2010) Ophthalmic manifestations of Stevens–Johnson syndrome and toxic epidermal necrolysis and relation to SCORTEN. Am J Ophthalmol 150(505–510):e501

    Google Scholar 

  19. Potvin R, Makari S, Rapuano CJ (2015) Tear film osmolarity and dry eye disease: a review of the literature. Clin ophthalmol (Auckland, NZ) 9:2039–2047

  20. Lemp MA, Bron AJ, Baudouin C, Benitez Del Castillo JM, Geffen D, Tauber J, Foulks GN, Pepose JS, Sullivan BD (2011) Tear osmolarity in the diagnosis and management of dry eye disease. Am J Ophthalmol 151(792–798):e791

    Google Scholar 

  21. Behrens A, Doyle JJ, Stern L, Chuck RS, McDonnell PJ, Azar DT, Dua HS, Hom M, Karpecki PM, Laibson PR, Lemp MA, Meisler DM, Del Castillo JM, O’Brien TP, Pflugfelder SC, Rolando M, Schein OD, Seitz B, Tseng SC, van Setten G, Wilson SE, Yiu SC (2006) Dysfunctional tear syndrome: a Delphi approach to treatment recommendations. Cornea 25:900–907

    Article  PubMed  Google Scholar 

  22. Gueudry J, Roujeau JC, Binaghi M, Soubrane G, Muraine M (2009) Risk factors for the development of ocular complications of Stevens–Johnson syndrome and toxic epidermal necrolysis. Arch Dermatol 145:157–162

    PubMed  Google Scholar 

  23. Biber JM, Skeens HM, Neff KD, Holland EJ (2011) The cincinnati procedure: technique and outcomes of combined living-related conjunctival limbal allografts and keratolimbal allografts in severe ocular surface failure. Cornea 30:765–771

    Article  PubMed  Google Scholar 

  24. Alexander JK, Basak SK, Padilla MD, Yu F, Aldave AJ (2015) International outcomes of the Boston Type I keratoprosthesis in Stevens–Johnson syndrome. Cornea 34:1387–1394

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alex L. K. Ng.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chow, L.L.W., Ng, A.L.K., Chow, S.S.W. et al. A cross-sectional comparative study on chronic ocular manifestations of Stevens–Johnson syndrome and toxic epidermal necrolysis in Chinese eyes: a 15-year case series. Int Ophthalmol 38, 1155–1160 (2018). https://doi.org/10.1007/s10792-017-0576-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-017-0576-5

Keywords

Navigation